<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(11)</volume><submitter>Houdayer C</submitter><funding>Genome Canada and the Ontario Genomics Institute</funding><funding>University of Zurich clinical research priority program praeclare</funding><pubmed_abstract>Rare genetic variants in ARID2 are responsible for a recently described neurodevelopmental condition called ARID2-related disorder (ARID2-RD). ARID2 belongs to PBAF, a unit of the SWI/SNF complex, which is a chromatin remodeling complex. This work aims to further delineate the phenotypic spectrum of ARID2-RD, providing clinicians with additional data for better care and aid in the future diagnosis of this condition. We obtained the genotypes and phenotypes of 27 previously unreported individuals with ARID2-RD and compared this series with findings in the literature. We also assessed peripheral blood DNA methylation profiles in individuals with ARID2-RD compared to episignatures of controls, unresolved cases, and other neurodevelopmental disorders. The main clinical features of ARID2-RD are</pubmed_abstract><journal>European journal of human genetics : EJHG</journal><pagination>1422-1431</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12583565</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>ARID2-related disorder: further delineation of the clinical phenotype of 27 novel individuals and description of an epigenetic signature.</pubmed_title><pmcid>PMC12583565</pmcid><pubmed_authors>Keren B</pubmed_authors><pubmed_authors>Desir J</pubmed_authors><pubmed_authors>van der Laan L</pubmed_authors><pubmed_authors>Rondeau S</pubmed_authors><pubmed_authors>Gripp KW</pubmed_authors><pubmed_authors>Alders M</pubmed_authors><pubmed_authors>Denomme-Pichon AS</pubmed_authors><pubmed_authors>Legoff L</pubmed_authors><pubmed_authors>Delanne J</pubmed_authors><pubmed_authors>Milon V</pubmed_authors><pubmed_authors>Mau-Them FT</pubmed_authors><pubmed_authors>Van der Sluijs PJ</pubmed_authors><pubmed_authors>Procaccio V</pubmed_authors><pubmed_authors>Sadikovic B</pubmed_authors><pubmed_authors>Bruel AL</pubmed_authors><pubmed_authors>Colin E</pubmed_authors><pubmed_authors>Vitobello A</pubmed_authors><pubmed_authors>Prouteau C</pubmed_authors><pubmed_authors>Rauch A</pubmed_authors><pubmed_authors>Thauvin-Robinet C</pubmed_authors><pubmed_authors>Bris C</pubmed_authors><pubmed_authors>Carallis F</pubmed_authors><pubmed_authors>Goldenberg A</pubmed_authors><pubmed_authors>Jacquinet A</pubmed_authors><pubmed_authors>Steindl K</pubmed_authors><pubmed_authors>Patat O</pubmed_authors><pubmed_authors>Bahr A</pubmed_authors><pubmed_authors>Isidor B</pubmed_authors><pubmed_authors>Trost D</pubmed_authors><pubmed_authors>Philippe C</pubmed_authors><pubmed_authors>Houdayer C</pubmed_authors><pubmed_authors>Tessarech M</pubmed_authors><pubmed_authors>Sorlin A</pubmed_authors><pubmed_authors>Mendelsohn BA</pubmed_authors><pubmed_authors>Rooney K</pubmed_authors><pubmed_authors>Bournez M</pubmed_authors><pubmed_authors>Relator R</pubmed_authors><pubmed_authors>Buhas D</pubmed_authors><pubmed_authors>McConkey H</pubmed_authors><pubmed_authors>Mignot C</pubmed_authors><pubmed_authors>Dubourg C</pubmed_authors><pubmed_authors>Demaret T</pubmed_authors><pubmed_authors>Rambaud T</pubmed_authors><pubmed_authors>Whalen S</pubmed_authors><pubmed_authors>Bourges A</pubmed_authors><pubmed_authors>Guimier A</pubmed_authors><pubmed_authors>Bonneau D</pubmed_authors><pubmed_authors>Oneda B</pubmed_authors><pubmed_authors>Pasquier L</pubmed_authors><pubmed_authors>Santen GWE</pubmed_authors><pubmed_authors>Battault C</pubmed_authors><pubmed_authors>Begemann A</pubmed_authors><pubmed_authors>Schleit J</pubmed_authors><pubmed_authors>Boughalem A</pubmed_authors><pubmed_authors>Cormier-Daire V</pubmed_authors><pubmed_authors>Goel H</pubmed_authors><pubmed_authors>Tedder M</pubmed_authors><pubmed_authors>Genevieve D</pubmed_authors><pubmed_authors>Vincent M</pubmed_authors><pubmed_authors>Bonnevalle A</pubmed_authors><pubmed_authors>Fradin M</pubmed_authors><pubmed_authors>Levy MA</pubmed_authors><pubmed_authors>Procopio R</pubmed_authors><pubmed_authors>Nizon M</pubmed_authors><pubmed_authors>Barcia G</pubmed_authors><pubmed_authors>Guichet A</pubmed_authors><pubmed_authors>Cogne B</pubmed_authors></additional><is_claimable>false</is_claimable><name>ARID2-related disorder: further delineation of the clinical phenotype of 27 novel individuals and description of an epigenetic signature.</name><description>Rare genetic variants in ARID2 are responsible for a recently described neurodevelopmental condition called ARID2-related disorder (ARID2-RD). ARID2 belongs to PBAF, a unit of the SWI/SNF complex, which is a chromatin remodeling complex. This work aims to further delineate the phenotypic spectrum of ARID2-RD, providing clinicians with additional data for better care and aid in the future diagnosis of this condition. We obtained the genotypes and phenotypes of 27 previously unreported individuals with ARID2-RD and compared this series with findings in the literature. We also assessed peripheral blood DNA methylation profiles in individuals with ARID2-RD compared to episignatures of controls, unresolved cases, and other neurodevelopmental disorders. The main clinical features of ARID2-RD are</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T11:51:19.491Z</modification><creation>2026-05-16T03:12:42.004Z</creation></dates><accession>S-EPMC12583565</accession><cross_references><pubmed>40044822</pubmed><doi>10.1038/s41431-025-01798-w</doi></cross_references></HashMap>